z-logo
open-access-imgOpen Access
Identification of a novel breast cancer‑causing mutation in the BRCA1 gene by targeted next generation sequencing: A case report
Author(s) -
Yanyan Wang,
Da Jiang,
Qiang Zhao,
Hui Huang,
Xue Zhang,
Yanzhi Cui,
Jiayin Liu,
Jing Wu,
Keke Lin,
Weixi Chen,
Jiale Xiang,
Hui Jin,
Zhiyu Peng,
Santasree Banerjee
Publication year - 2018
Publication title -
oncology letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.766
H-Index - 54
eISSN - 1792-1082
pISSN - 1792-1074
DOI - 10.3892/ol.2018.9139
Subject(s) - breast cancer , oncogene , molecular medicine , identification (biology) , cancer , dna sequencing , cell cycle , mutation , gene , biology , genetics , computational biology , cancer research , botany
Hereditary breast cancer is an autosomal dominant syndrome caused by germ-line mutations in the human breast cancer genes, BRCA1 and BRCA2 . Mutations in either BRCA1 or BRCA2 are the major causes of familial and early-onset breast cancer. The present study investigated a 33-year-old Chinese female patient with breast cancer using targeted next generation sequencing. A novel heterozygous deletion-insertion was also identified in the BRCA1 gene, c.311_312delinsAGGTTTGCA, which causes the formation of a truncated BRCA1 protein of 109 amino acids instead of a wild-type BRCA1 protein of 1,863 amino acids. These results could potentially expand the mutational spectra of BRCA1-associated breast cancer. In addition, these findings may be valuable for the mutation-based screening and genetic diagnosis of breast cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom